NewMarket (NEU) Q1 2026 Earnings Transcript

NewMarket reported Q1 net income of $118 million, down from $126 million, and EPS of $12.62 versus $13.26 a year ago. Petroleum additives sales fell to $610 million from $646 million as shipments declined 7% amid softer demand and lower-margin business reductions, though management noted a late-quarter pickup and maintained a strong operating margin. Specialty Materials sales rose to $58 million from $54 million on the Calco acquisition, but operating profit dropped to $12 million from $23 million; the company also returned $104 million to shareholders and ended the quarter with net debt to EBITDA of 1.2x.

Analysis

NEU’s print reads better than the headline suggests: the company is actively pruning low-margin volume while pushing through pricing and rebalancing production, which is exactly what you want in a cost-push environment if the end market is only mildly soft. The second-order implication is that this business has more pricing power and supply-chain flexibility than a plain-vanilla cyclicals screen implies; if shipments inflect even modestly from the late-quarter improvement, operating leverage can rebound quickly because the fixed-cost base is already being managed around a smaller, cleaner mix.

The key market misread is likely to be on specialty materials volatility. Investors may anchor on the year-over-year profit drop, but management is signaling that quarterly noise is structural, not a demand collapse; that means the right question is not whether the next quarter is up or down, but whether Calco’s contribution becomes large enough to dilute Ampak mix volatility over the next 2-4 quarters. If so, the segment could become a valuation stabilizer rather than a reported earnings swing factor.

Capital return remains the most underappreciated support to the stock. With leverage at 1.2x and cash generation still covering repurchases/dividends comfortably, NEU has room to keep shrinking share count while waiting for additive margin recovery; that makes downside on a multiple basis more defensive than the operating numbers alone imply. The main tail risk is sustained input inflation combined with weaker volume, which would force more pricing and potentially expose customer churn, but that looks like a months-long risk rather than a near-term dislocation.

Contrarian setup: this is not a momentum long; it is a quality compounder buying opportunity on any post-earnings de-rating. The market is probably over-penalizing the shipment decline because it is conflating deliberate mix management with cyclical weakness, while underestimating how quickly margins can snap back if market softness eases and the production network stays aligned. In a broader industrials tape, NEU should trade as a defensive cash-return story with hidden operating torque, not a pure volume recovery name.

Key Decisions for Investors

• Long NEU on pullbacks over the next 1-3 weeks; target a 6-10% move if investors re-rate the stock toward cash-return stability and margin resilience. Risk: another quarter of weak shipments; stop if volume deterioration broadens beyond the deliberate low-margin exit.
• Pair trade: long NEU / short a more volume-sensitive specialty chemicals or industrial inputs name with weaker pricing power over a 1-2 quarter horizon. Thesis: NEU has better downside protection from pricing, production flexibility, and buybacks.
• Sell put spreads in NEU 2-3 months out at strikes ~5-8% below spot if liquidity is adequate. Risk/reward favors collecting premium while leverage and shareholder returns put a floor under the equity, but only if you are comfortable with cyclical downside.
• If you already own NEU, hold through the next quarter rather than trading the print; the setup improves if late-quarter shipment strength carries into Q2. Trim only if management tone shifts from mix management to outright demand weakness.